291 related articles for article (PubMed ID: 23372019)
1. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators.
Leach K; Wen A; Cook AE; Sexton PM; Conigrave AD; Christopoulos A
Endocrinology; 2013 Mar; 154(3):1105-16. PubMed ID: 23372019
[TBL] [Abstract][Full Text] [Related]
2. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
Davey AE; Leach K; Valant C; Conigrave AD; Sexton PM; Christopoulos A
Endocrinology; 2012 Mar; 153(3):1232-41. PubMed ID: 22210744
[TBL] [Abstract][Full Text] [Related]
3. Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Babinsky VN; Hannan FM; Gorvin CM; Howles SA; Nesbit MA; Rust N; Hanyaloglu AC; Hu J; Spiegel AM; Thakker RV
J Biol Chem; 2016 May; 291(20):10876-85. PubMed ID: 26994139
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Ca(2+) oscillations generated via the extracellular Ca(2+)-sensing receptor (CaSR) in response to extracellular Ca(2+) or L-phenylalanine: Impact of the highly conservative mutation Ser170Thr.
Young SH; Rey O; Rozengurt E
Biochem Biophys Res Commun; 2015 Nov; 467(1):1-6. PubMed ID: 26431875
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143.
Nakamura A; Hotsubo T; Kobayashi K; Mochizuki H; Ishizu K; Tajima T
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1692-701. PubMed ID: 23966241
[TBL] [Abstract][Full Text] [Related]
6. Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Josephs TM; Zhang F; Dinh LV; Keller AN; Conigrave AD; Capuano B; Gregory KJ; Leach K
J Mol Endocrinol; 2022 May; 69(1):243-257. PubMed ID: 35318962
[TBL] [Abstract][Full Text] [Related]
7. Receptor expression modulates calcium-sensing receptor mediated intracellular Ca2+ mobilization.
Brennan SC; Mun HC; Leach K; Kuchel PW; Christopoulos A; Conigrave AD
Endocrinology; 2015 Apr; 156(4):1330-42. PubMed ID: 25607893
[TBL] [Abstract][Full Text] [Related]
8. Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.
Avlani VA; Ma W; Mun HC; Leach K; Delbridge L; Christopoulos A; Conigrave AD
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1097-104. PubMed ID: 23531616
[TBL] [Abstract][Full Text] [Related]
9. Calcium-Sensing Receptor Internalization Is
Mos I; Jacobsen SE; Foster SR; Bräuner-Osborne H
Mol Pharmacol; 2019 Oct; 96(4):463-474. PubMed ID: 31399503
[TBL] [Abstract][Full Text] [Related]
10. Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors.
Letz S; Rus R; Haag C; Dörr HG; Schnabel D; Möhlig M; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
J Clin Endocrinol Metab; 2010 Oct; 95(10):E229-33. PubMed ID: 20668040
[TBL] [Abstract][Full Text] [Related]
11. Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants.
White E; McKenna J; Cavanaugh A; Breitwieser GE
Mol Endocrinol; 2009 Jul; 23(7):1115-23. PubMed ID: 19389809
[TBL] [Abstract][Full Text] [Related]
12. Recent updates on the calcium-sensing receptor as a drug target.
Trivedi R; Mithal A; Chattopadhyay N
Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
[TBL] [Abstract][Full Text] [Related]
13. Agonist-driven maturation and plasma membrane insertion of calcium-sensing receptors dynamically control signal amplitude.
Grant MP; Stepanchick A; Cavanaugh A; Breitwieser GE
Sci Signal; 2011 Nov; 4(200):ra78. PubMed ID: 22114145
[TBL] [Abstract][Full Text] [Related]
14. International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.
Leach K; Hannan FM; Josephs TM; Keller AN; Møller TC; Ward DT; Kallay E; Mason RS; Thakker RV; Riccardi D; Conigrave AD; Bräuner-Osborne H
Pharmacol Rev; 2020 Jul; 72(3):558-604. PubMed ID: 32467152
[TBL] [Abstract][Full Text] [Related]
15. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain.
Petrel C; Kessler A; Dauban P; Dodd RH; Rognan D; Ruat M
J Biol Chem; 2004 Apr; 279(18):18990-7. PubMed ID: 14976203
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator].
Nagano N; Tsutsui T
Clin Calcium; 2016 Jun; 26(6):839-50. PubMed ID: 27230839
[TBL] [Abstract][Full Text] [Related]
17. Role of Ca2+ and L-Phe in regulating functional cooperativity of disease-associated "toggle" calcium-sensing receptor mutations.
Zhang C; Mulpuri N; Hannan FM; Nesbit MA; Thakker RV; Hamelberg D; Brown EM; Yang JJ
PLoS One; 2014; 9(11):e113622. PubMed ID: 25420019
[TBL] [Abstract][Full Text] [Related]
18. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoperones and the calcium sensing receptor: exogenous and endogenous regulators.
Breitwieser GE
Pharmacol Res; 2014 May; 83():30-7. PubMed ID: 24291533
[TBL] [Abstract][Full Text] [Related]
20. Regulation of stability and trafficking of calcium-sensing receptors by pharmacologic chaperones.
Huang Y; Cavanaugh A; Breitwieser GE
Adv Pharmacol; 2011; 62():143-73. PubMed ID: 21907909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
